From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
Tian, N.; Li, J.; Shi, J.; Sui, G. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. Int. J. Mol. Sci. 2017, 18, 191. https://doi.org/10.3390/ijms18030191
Tian N, Li J, Shi J, Sui G. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. International Journal of Molecular Sciences. 2017; 18(3):191. https://doi.org/10.3390/ijms18030191
Chicago/Turabian StyleTian, Na, Jialiang Li, Jinming Shi, and Guangchao Sui. 2017. "From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform" International Journal of Molecular Sciences 18, no. 3: 191. https://doi.org/10.3390/ijms18030191